Regulating Antimicrobial action: The EMA approach

Jan. 21, 2013 - PRLog -- This discussion led event will bring together senior Pharma representatives and key academics to discuss current developments in this fast-paced field. With presentations from industry representatives from all over the pharmaceutical sector, this event promises to be a unique platform for networking and problem solving.

SMi is pleased to confirm Line Matthiesen, Head of Infectious Diseases and Public Health Unit, European Commission as a speaker at the upcoming event.  
He will discuss meeting the challenges in implementing the European Commission’s Action plan on antimicrobial resistance, partnerships with industry on antimicrobial resistance, partnerships among countries on antimicrobial resistance and the vision on future research under Horizon 2020.

Attending this event will enable delegates to hear:

·         Over 16 international speakers from top pharma companies, BARDA, top universities, The European Commission and EFPIA

·         Case study on mechanisms of action for inhibiting antibiotics

·         Unparalleled multi-disciplinary networking opportunities

·         Hot topic sessions on combating fungal infections and regulatory requirements for antimicrobial developers

·         A focus on the discovery and development of novel antiviral agents at Johnson & Johnson

For more information or to book your place visit http://www.smi-online.co.uk/goto/superbugssuperdrugs38.asp
 Or Contact Fateja Begum on +44 0 207 827 6184 or email fbegum@smi-online.co.uk